Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer

A. M. W. M. Aarts*, S. W. Duffy, S. M. E. Geurts, D. P. Vulkan, N. Houssami, M. Zappa, I. D. Nagtegaal, A. L. M. Verbeek, M. J. M. Broeders

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)70-74
Number of pages5
JournalBreast
Volume45
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Second primary breast cancer
  • Preclinical detectable phase
  • Test sensitivity
  • Mammography
  • Clinical breast examination
  • TEST SENSITIVITY
  • STAGE
  • PARAMETERS
  • PROGNOSIS
  • PROGRAM
  • DENSITY
  • HISTORY
  • TIME

Cite this

Aarts, A. M. W. M., Duffy, S. W., Geurts, S. M. E., Vulkan, D. P., Houssami, N., Zappa, M., Nagtegaal, I. D., Verbeek, A. L. M., & Broeders, M. J. M. (2019). Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. Breast, 45, 70-74. https://doi.org/10.1016/j.breast.2019.03.003